CAS 863288-34-0

CJC 1295

Beschreibung:

CJC-1295 ist ein synthetisches Peptid, das als Analogon des Wachstumshormon-freisetzenden Hormons (GHRH) fungiert. Es wird hauptsächlich in Forschungseinrichtungen verwendet, um seine Auswirkungen auf die Sekretion von Wachstumshormonen und potenzielle therapeutische Anwendungen zu untersuchen. CJC-1295 zeichnet sich durch seine Fähigkeit aus, die Hypophyse zu stimulieren, Wachstumshormon freizusetzen, was zu einer erhöhten Muskelmasse, Fettabbau und verbesserter Erholung führen kann. Das Peptid hat aufgrund seiner Modifikation eine lange Halbwertszeit, die eine nachhaltige Freisetzung und verlängerte Aktivität im Körper ermöglicht. Es wird typischerweise durch subkutane Injektion verabreicht. CJC-1295 wird häufig im Kontext von Anti-Aging, Bodybuilding und Stoffwechselstörungen untersucht, obwohl seine Verwendung bei Menschen außerhalb der Forschung von den Regulierungsbehörden nicht genehmigt ist. Wie bei jedem Peptid sind Reinheit, Dosierung und Verabreichungsweg entscheidend für seine Wirksamkeit und Sicherheit. Forscher müssen sich an ethische Richtlinien und Vorschriften halten, wenn sie mit dieser Verbindung umgehen und sie untersuchen.

Formel: Unspecified

Synonyme:

• <span class="text-smallcaps">L</smallcap>-Lysinamide, <smallcap>L</smallcap>-tyrosyl-<smallcap>D</smallcap>-alanyl-<smallcap>L</smallcap>-α-aspartyl-<smallcap>L</smallcap>-alanyl-<smallcap>L</smallcap>-isoleucyl-<smallcap>L</smallcap>-phenylalanyl-<smallcap>L</smallcap>-threonyl-<smallcap>L</smallcap>-glutaminyl-<smallcap>L</smallcap>-seryl-<smallcap>L</smallcap>-tyrosyl-<smallcap>L</smallcap>-arginyl-<smallcap>L</smallcap>-lysyl-<smallcap>L</smallcap>-valyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-alanyl-<smallcap>L</smallcap>-glutaminyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-seryl-<smallcap>L</smallcap>-alanyl-<smallcap>L</smallcap>-arginyl-<smallcap>L</smallcap>-lysyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-glutaminyl-<smallcap>L</smallcap>-α-aspartyl-<smallcap>L</smallcap>-isoleucyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-seryl-<smallcap>L</span>-arginyl-N⁶-[3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]-
• <span class="text-smallcaps">L</smallcap>-Tyrosyl-<smallcap>D</smallcap>-alanyl-<smallcap>L</smallcap>-α-aspartyl-<smallcap>L</smallcap>-alanyl-<smallcap>L</smallcap>-isoleucyl-<smallcap>L</smallcap>-phenylalanyl-<smallcap>L</smallcap>-threonyl-<smallcap>L</smallcap>-glutaminyl-<smallcap>L</smallcap>-seryl-<smallcap>L</smallcap>-tyrosyl-<smallcap>L</smallcap>-arginyl-<smallcap>L</smallcap>-lysyl-<smallcap>L</smallcap>-valyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-alanyl-<smallcap>L</smallcap>-glutaminyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-seryl-<smallcap>L</smallcap>-alanyl-<smallcap>L</smallcap>-arginyl-<smallcap>L</smallcap>-lysyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-glutaminyl-<smallcap>L</smallcap>-α-aspartyl-<smallcap>L</smallcap>-isoleucyl-<smallcap>L</smallcap>-leucyl-<smallcap>L</smallcap>-seryl-<smallcap>L</smallcap>-arginyl-N⁶-[3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]-<smallcap>L</span>-lysinamide
• Cjc 1295
• L-Tyrosyl-D-alanyl-L-α-aspartyl-L-alanyl-L-isoleucyl-L-phenylalanyl-L-threonyl-L-glutaminyl-L-seryl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucyl-L-alanyl-L-glutaminyl-L-leucyl-L-seryl-L-alanyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-α-aspartyl-L-isoleucyl-L-leucyl-L-seryl-L-arginyl-N6-[3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]-L-lysinamide
• L-Lysinamide, L-tyrosyl-D-alanyl-L-α-aspartyl-L-alanyl-L-isoleucyl-L-phenylalanyl-L-threonyl-L-glutaminyl-L-seryl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucyl-L-alanyl-L-glutaminyl-L-leucyl-L-seryl-L-alanyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-α-aspartyl-L-isoleucyl-L-leucyl-L-seryl-L-arginyl-N6-[3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]-

CJC-1295

CAS: 863288-34-0

Formel: C₁₅₂H₂₅₂N₄₄O₄₂

Reinheit: 95%~99%

Farbe und Form: White to Off-white Powder

Molekulargewicht: 3367.897

Ref: BP-BPPG019

CJC-1295

CAS: 863288-34-0

CJC-1295 is a synthetic peptide, which is an analogue of growth hormone-releasing hormone (GHRH). It is synthesized through recombinant DNA technology, which allows for precise control over its sequence and length. This particular peptide is designed to bind to GHRH receptors in the pituitary gland. By activating these receptors, CJC-1295 stimulates the release of growth hormone (GH) into the bloodstream.The primary function of CJC-1295 is to influence the endocrine system, particularly enhancing the release of endogenous growth hormone. It achieves this by increasing the amplitude and frequency of GH pulses without affecting the natural negative feedback mechanisms that regulate GH production. This mode of action distinguishes CJC-1295 from other growth hormone therapies, as it promotes a more physiological pattern of hormone secretion.CJC-1295 is used in various scientific contexts, primarily in research focusing on growth hormone deficiencies, muscle wasting conditions, and certain metabolic disorders. Its ability to increase GH release also makes it a subject of interest in studies related to aging, tissue repair, and regeneration. The longer half-life of CJC-1295 compared to natural GHRH peptides further enhances its applications in research, allowing for more sustained and controlled experimentation.

Reinheit: Min. 95%

Ref: 3D-FC138107